It, however, argued against the use of statutory provisions like compulsory licensing to influence pricing of vaccines by the two domestic firms Serum Institute and Bharat Biotech saying given the financial risk the firms have taken, negotiated pricing would be a prudent approach...

https://www.financialexpress.com/lifestyle/health/covid-19-vaccination-strategy-equitable-and-just-centre-tells-supreme-court/2249547/

#TheFinancialExpress